Articles by Jennifer Markarian - BioPharm International



Articles by Jennifer Markarian

Eli Lilly Announces 2013 Financial Guidance

Jan 8, 2013

Eli Lilly expects overall revenue growth in the coming year.

US Supreme Court to Hear Pay-for-Delay Case

Dec 11, 2012

The US Supreme Court accepted an appeal by the Federal Trade Commission of a decision that upheld an arrangement of payments by Solvay Pharmaceuticals to generic drug companies to postpone introduction of generic versions of its branded testosterone-replacement drug.

GSK Plans to Increase Stake in Indian and Nigerian Subsidiaries

Nov 27, 2012

GlaxoSmithKline announced its intent to increase ownership in its publicly-listed, consumer-healthcare subsidiary in India and in GlaxoSmithKline Consumer Nigeria as part of its emerging-markets investment strategy.

Precautionary Hold on Novartis Seasonal Influenza Vaccine Lifted

Nov 14, 2012

The Italian Medicines Agency lifted a temporary hold on the use of Novartis seasonal influenza vaccines in Italy after affirming the vaccines' safety and efficacy.

Third-Quarter 2012 Financial Reports Show Novartis and Merck Down

Oct 30, 2012

Pharmaceutical industry leaders Novartis and Merck—among others—released second-quarter 2012 results showing global sales down in third-quarter 2012, with growth in key pharmaceutical products helping to offset losses due to patent expirations.

New USP Standards Guide Prescription Container Labels

Oct 16, 2012

New US Pharmacopeial Convention (USP) standards provide a universal approach to organizing labels for prescription containers dispensed by US pharmacists in an effort to improve patient understanding.

Merck Plans to Move Global Headquarters within New Jersey

Oct 9, 2012

Merck will close its headquarters in Whitehouse Station, NJ and relocate to its existing facility in Summit, NJ, beginning in 2014.

Bayer HealthCare Acquires Teva's US Animal Health Business

Sep 18, 2012

Bayer expands animal health business with acquisition from Teva.

Pfizer Settles Patent Litigation with Mylan

Sep 11, 2012

Pfizer and Mylan have agreed on terms by which Mylan may launch its generic version of Pfizer's Detrol LA (tolterodine tartrate) extended-release capsules, pending final approval by FDA.



Click here